PULMONX CORP (LUNG)

US7458481014 - Common Stock

9.27  +0.16 (+1.76%)

After market: 9.27 0 (0%)

News Image
10 days ago - Market News Video

Pulmonx is Now Oversold (LUNG)

News Image
13 days ago - Pulmonx Corporation

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally...

News Image
a month ago - Market News Video

Pulmonx Corp Enters Oversold Territory (LUNG)

News Image
a month ago - Seeking Alpha

Pulmonx dips on Wells Fargo downgrade eyeing uncertainty over management changes

Pulmonx's stock fell 5% as Wells Fargo downgraded it due to management changes and uncertainty.

News Image
a month ago - Seeking Alpha

(NASDAQ:LUNG)

Pulmonx (LUNG) reports Q4 2023 earnings, beating expectations with a higher revenue of $19.27M and a GAAP EPS of -$0.36.

News Image
a month ago - Seeking Alpha

Pulmonx announces retirement of president and CEO Glen French (NASDAQ:LUNG)

Pulmonx appoints Steve Williamson as CEO, triggering a 2.1% rise in LUNG shares, while Glen French continues as advisor and board member until May 2024.

News Image
a month ago - Pulmonx Corporation

Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results

REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the

News Image
a month ago - Pulmonx Corporation

Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the

News Image
2 months ago - Pulmonx Corporation

Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

REDWOOD CITY, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments...

News Image
4 months ago - InvestorPlace

Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare

Are you looking for biotech breakthrough stocks? Here are three revolutionary stocks redefining healthcare.

News Image
4 months ago - Pulmonx Corporation

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

REDWOOD CITY, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments...

News Image
5 months ago - Pulmonx Corporation

Pulmonx to Participate at Upcoming Investor Conferences

REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments...

News Image
5 months ago - Pulmonx Corporation

Pulmonx Reports Record Third Quarter 2023 Financial Results

REDWOOD CITY, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the

News Image
5 months ago - Pulmonx Corporation

Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023

REDWOOD CITY, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments...

News Image
6 months ago - Market News Video

Pulmonx is Now Oversold (LUNG)

News Image
6 months ago - Seeking Alpha

Pulmonx announces departure of finance chief Derrick Sung (NASDAQ:LUNG)

Pulmonx announces CFO transition as Derrick Sung steps down, replaced by John McKune.

News Image
6 months ago - Pulmonx Corporation

Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue

Derrick Sung steps down from his position as Chief Financial Officer to pursue another opportunity; John McKune appointed Interim Chief Financial...